Skip to content
Issue / July 2026
Menu
Gut Metabolic

A food-science magazine on the gut microbiome and metabolic health — every claim sourced.

Feature

Best Probiotic Strains for Constipation (by Strain)

Probiotics for constipation are strain-specific. B. lactis HN019 and DN-173 010 shortened gut transit in RCTs — pick the studied strain, not just 'probiotic.'

By Priya Raman

Nutrition & Microbiome Editor ·

Contents

Editorial pick

CoreAge Rx — GLP-1 Support

From $23.83/bottle

Transparent, no-prescription daily probiotic for gut and metabolic support — three strains plus prebiotic fiber.

Shop CoreAge GLP-1 Support
Category
GLP-1 support · telehealth
Formulation
3 strains + prebiotic fiber
Access
No Rx

Advertising disclosure · we may earn a commission at no extra cost to you. It never changes our ranking.

Want the medication?

Sesame Care

An established national telehealth marketplace with the widest real brand-name GLP-1 access — actual FDA-approved Wegovy, Zepbound, Ozempic and more — for readers who want the medication, not a probiotic.

See if you qualify with Sesame Care

If you're constipated and reaching for a probiotic, the single most important thing to know is that "probiotic" is not one thing. Benefits for constipation are strain-specific: a particular bacterial strain, studied at a particular dose, that shortened gut transit or improved stool frequency in a real trial. Buying a generic "50-billion-CFU" bottle and hoping is a different gamble from buying a strain that actually has the constipation data behind it. This page is organized the way the evidence is — by strain — so you can match a product's label to a study rather than to a marketing claim.

The honest headline: a couple of Bifidobacterium animalis subspecies lactis strains — HN019 and DN-173 010 — have randomized human data showing they speed up colonic transit, and meta-analyses find probiotics as a category modestly improve constipation. But effects are moderate, not laxative-strength, and the major gastroenterology guideline still rates the overall evidence as insufficient to broadly recommend them. Strain selection is everything.

Why "strain-specific" isn't a technicality

A probiotic's identity has three parts: genus, species, and strain — for example Bifidobacterium (genus) animalis subsp. lactis (species) HN019 (strain). The strain is the part that was actually tested. Two strains of the same species can behave completely differently in the gut, and a constipation benefit shown for one strain does not transfer to another strain of the same species, let alone to a random multi-strain blend. This is why the meta-analyses, even when positive overall, repeatedly stress that effects vary by strain and can't be generalized 16. When you shop, the strain designation (the letters/numbers after the species) is the thing to match to a study.

Match the label to the study

OptionConstipation evidenceNotes
B. lactis HN019Transit-time RCT (28 days, dose-related)Cleanest mechanism-to-outcome; well tolerated
B. lactis DN-173 010Shortened colonic transit; better QoL/symptomsMostly studied as fermented milk, in women
Multi-strain blendsModest category benefit in meta-analysesStrongest for Bifidobacterium-containing; varies by strain
High-CFU, no strain dataNone specific to constipationCFU count ≠ a studied strain
Constipation benefit is strain-specific. The strain code on the label — not the CFU number — is what ties a product to a real trial.

The strains with the best constipation data

Bifidobacterium animalis subsp. lactis HN019

HN019 has the cleanest mechanism-to-outcome story for constipation. In a randomized, double-blind, placebo-controlled trial, 28 days of HN019 supplementation shortened whole-gut transit time in adults with functional GI symptoms, with a dose-related effect — the marker most directly tied to constipation 2. A later review of HN019's gut-health effects summarizes converging evidence that it improves transit and bowel-movement regularity and is well tolerated 3. Of the widely sold strains, HN019 is the one whose constipation claim rests most directly on a transit-time RCT.

Bifidobacterium animalis subsp. lactis DN-173 010 (the "Activia" strain)

DN-173 010 is the strain made famous in fermented-milk products. It also has genuine transit-time data: in a double-blind study, DN-173 010 shortened colonic transit time in healthy women 4, and a separate randomized trial found a fermented milk containing it improved health-related quality of life and digestive symptoms in women with constipation and bloating 5. The caveat is that much of this work used the specific fermented-milk format and female participants, so it's best read as solid for that strain-and-format rather than proof that any DN-173 010 capsule works identically.

Multi-strain blends and the broader category

Beyond those two named strains, the evidence gets fuzzier but isn't empty. Meta-analyses pooling many products find that probiotics, taken together, modestly increase stool frequency and shorten transit time in constipated adults 167, and a separate review found benefit in constipation-predominant IBS specifically 8. The signal is real but moderate, and it's strongest for Bifidobacterium-containing products — which is why the two strains above anchor the category.

The honest limits: what probiotics for constipation can't do

This is the part the supplement aisle skips. Three caveats keep the claims grounded:

The effect is modest, not laxative-strength. Transit time shortens by a meaningful but not dramatic amount, and stool frequency ticks up — these are real improvements for mild, functional constipation, not a treatment for severe or obstructive constipation, which needs medical evaluation.

The top guideline is cautious. The American Gastroenterological Association's clinical guidelines on probiotics concluded there was insufficient evidence to recommend probiotics for most GI conditions, including constipation, outside of a clinical trial 9. That doesn't mean they don't work — it reflects heterogeneous strains, small studies, and inconsistent endpoints. But it's the honest counterweight to confident marketing.

Strain and format matter more than CFU count. A huge CFU number on a strain with no constipation data is worth less than a modest dose of HN019 or DN-173 010. Don't pay for potency in the wrong bug.

How strong is each claim?

  • B. lactis HN019 → shorter gut transitModerate evidence

    Randomized, double-blind, placebo-controlled trial; dose-related transit improvement (Ibarra 2018).

  • B. lactis DN-173 010 → shorter transit / better symptomsModerate evidence

    Transit-time and quality-of-life RCTs, largely fermented-milk format in women (Marteau 2002; Guyonnet 2007).

  • Probiotics (category) → modest constipation benefitModerate evidence

    Meta-analyses show small increases in stool frequency and shorter transit; effects vary by strain (Dimidi 2014; Miller 2016/2017).

  • High-CFU products without strain dataNone evidence

    CFU count does not substitute for a strain with constipation evidence.

  • Probiotics replace fiber/fluid/medical careNone evidence

    Adjuncts only; severe or alarm-feature constipation needs clinical evaluation.

Real but moderate. The major gastroenterology guideline still rates the overall evidence as insufficient for a blanket recommendation.

How to actually use them

  • Match the label to a study. Look for B. lactis HN019 or DN-173 010 by their strain codes, not just "Bifidobacterium" or a CFU headline.
  • Give it weeks, not days. The transit-time RCTs ran around four weeks; judge results over a month, not a few doses.
  • Keep the basics in place. Probiotics work best alongside adequate fiber and fluid, not instead of them — the foundational levers for regularity. For timing nuances, see the best time to take probiotics.
  • Mind the startup window. Some people get transient gas or bloating in the first week or two; that often settles. We unpack the bloating-vs-benefit question in bloating and weight.
  • Escalate red flags. New, severe, or alarm-feature constipation (blood, unexplained weight loss, sudden change) is a see-a-clinician situation, not a supplement one.

The bottom line

Bottom line

Pick the studied strain, give it a month

  • Constipation benefit is strain-specific — match the strain code on the label to a real trial, not the CFU headline.
  • B. lactis HN019 and DN-173 010 are the two strains with randomized data showing shorter gut transit and better regularity.
  • Category meta-analyses show a modest overall benefit; the AGA guideline still rates the evidence insufficient for a blanket recommendation.
  • Effects are moderate, not laxative-strength — keep adequate fiber and fluid in place and judge over about four weeks.
  • New, severe, or alarm-feature constipation needs a clinician, not a supplement.

Probiotics can modestly help functional constipation, but only if you treat the choice as strain-specific rather than generic. Bifidobacterium animalis subsp. lactis HN019 and DN-173 010 are the two strains with randomized human data showing shorter gut transit and better regularity, and category-level meta-analyses back a moderate overall benefit — while the leading gastroenterology guideline still rates the evidence as insufficient for a blanket recommendation. So pick the studied strain, give it a month, keep fiber and fluid in place, and set expectations to "modest, real improvement," not "a laxative." For our full evidence-tiered product picks, see best gut-health supplements and the best metabolic probiotic hub; for the broader gut-to-metabolism picture, start with the gut–metabolism connection pillar.

Probiotics for constipation are strain-specific. B. lactis HN019 and DN-173 010 shortened gut transit in RCTs — pick the studied strain, not just 'probiotic.'
Gut Metabolic — the short version

Reader questions

Which probiotic strain is best for constipation?

The two strains with the strongest randomized data are both Bifidobacterium animalis subsp. lactis: HN019, which shortened whole-gut transit time in a 28-day placebo-controlled trial, and DN-173 010 (the strain in some fermented-milk products), which shortened colonic transit and improved digestive symptoms and quality of life. Constipation benefit is strain-specific, so look for those exact strain codes on the label rather than just 'Bifidobacterium' or a high CFU number.

Do probiotics actually work for constipation?

Modestly, for functional constipation. Meta-analyses find probiotics as a group slightly increase stool frequency and shorten gut transit, with the best signal for Bifidobacterium-containing products. But effects are moderate rather than laxative-strength, vary a lot by strain, and the American Gastroenterological Association's guideline still rates the overall evidence as insufficient for a blanket recommendation outside clinical trials. They're a reasonable adjunct, not a cure.

Does a higher CFU count mean a better probiotic for constipation?

No. CFU (the number of live organisms) is not what determines whether a product helps constipation — the strain is. A very high CFU count on a strain with no constipation data is worth less than a modest dose of a studied strain like HN019 or DN-173 010. Match the strain code to a real trial first, then consider dose.

How long do probiotics take to help constipation?

Give it about four weeks. The transit-time trials for HN019 and DN-173 010 ran roughly 28 days, so judge results over a month rather than a few doses. Keep adequate fiber and fluid in place at the same time, since probiotics work best alongside those basics, not instead of them. If constipation is new, severe, or comes with alarm features like blood or weight loss, see a clinician instead.

Sources

  1. Dimidi E, Christodoulides S, Fragkos KC, et al. (2014). The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/25099542/
  2. Ibarra A, Latreille-Barbier M, Donazzolo Y, et al. (2018). Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a randomized, double-blind, placebo-controlled trial. Gut Microbes. https://pubmed.ncbi.nlm.nih.gov/29227175/
  3. Cheng J, Laitila A, Ouwehand AC (2021). Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/34970580/
  4. Marteau P, Cuillerier E, Meance S, et al. (2002). Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Alimentary Pharmacology & Therapeutics. https://pubmed.ncbi.nlm.nih.gov/11876714/
  5. Guyonnet D, Chassany O, Ducrotte P, et al. (2007). Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics. https://pubmed.ncbi.nlm.nih.gov/17635382/
  6. Miller LE, Ouwehand AC, Ibarra A (2017). Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Annals of Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/29118557/
  7. Miller LE, Zimmermann AK, Ouwehand AC (2016). Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World Journal of Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/27275105/
  8. Wen Y, Li J, Long Q, et al. (2020). The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis based on seventeen randomized controlled trials. International Journal of Surgery. https://pubmed.ncbi.nlm.nih.gov/32387213/
  9. Su GL, Ko CW, Bercik P, et al. (2020). AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/32531291/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.